These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22171621)

  • 61. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies.
    Hedner U
    Thromb Haemost; 2008 Oct; 100(4):557-62. PubMed ID: 18841276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
    Steen Carlsson K; Astermark J; Donfield S; Berntorp E
    Thromb Haemost; 2008 Jun; 99(6):1060-7. PubMed ID: 18521509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program.
    Arkin S; Cooper HA; Hutter JJ; Miller S; Schmidt ML; Seibel NL; Shapiro A; Warrier I
    Haemostasis; 1998; 28(2):93-8. PubMed ID: 10087434
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors.
    Kenet G; Martinowitz U
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S38-41. PubMed ID: 18544424
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NovoSeven in immune tolerance therapy.
    Brackmann HH; Effenberger E; Hess L; Schwaab R; Oldenburg J
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S39-44. PubMed ID: 10850563
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.
    Stephens JM; Joshi AV; Sumner M; Botteman MF
    Expert Opin Pharmacother; 2007 Jun; 8(8):1127-36. PubMed ID: 17516876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors.
    Seremetis S
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S29-30. PubMed ID: 14567532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients.
    Ng HJ; Lee LH
    Vasc Health Risk Manag; 2006; 2(4):433-40. PubMed ID: 17323597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.
    Young G; McDaniel M; Nugent DJ
    Haemophilia; 2005 May; 11(3):203-7. PubMed ID: 15876264
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
    Livnat T; Martinowitz U; Azar-Avivi S; Zivelin A; Brutman-Barazani T; Lubetsky A; Kenet G
    Haemophilia; 2013 Sep; 19(5):782-9. PubMed ID: 23659442
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
    Mauser-Bunschoten EP; Koopman MM; Goede-Bolder AD; Leebeek FW; van der Meer J; van Marwijk Kooij GM; van der Linden PW;
    Haemophilia; 2002 Sep; 8(5):649-56. PubMed ID: 12199674
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systematic literature review of economics analysis on treatment of mild-to-moderate bleeds with aPCC versus rFVIIa.
    Hay JW; Zhou ZY
    J Med Econ; 2011; 14(4):516-25. PubMed ID: 21699366
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
    Gruppo RA; Malan D; Kapocsi J; Nemes L; Hay CRM; Boggio L; Chowdary P; Tagariello G; von Drygalski A; Hua F; Scaramozza M; Arkin S;
    J Thromb Haemost; 2018 Oct; 16(10):1984-1993. PubMed ID: 30151972
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.
    Amano K; Seita I; Higasa S; Sawada A; Kuwahara M; Shima M
    Haemophilia; 2017 Jan; 23(1):50-58. PubMed ID: 27457022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
    Salaj P; Brabec P; Penka M; Pohlreichova V; Smejkal P; Cetkovsky P; Dusek L; Hedner U
    Haemophilia; 2009 May; 15(3):752-9. PubMed ID: 19432926
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia.
    Dehmel H; Werwitzke S; Trummer A; Ganser A; Tiede A
    Haemophilia; 2008 Jul; 14(4):736-42. PubMed ID: 18445011
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label.
    Croteau SE; Nakar C; Neufeld EJ; Shapiro A; Cooper DL
    Pediatr Blood Cancer; 2016 Oct; 63(10):1822-8. PubMed ID: 27232114
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
    Qi X; Zhao Y; Li K; Fan L; Hua B
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):754-60. PubMed ID: 24806320
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
    Schneiderman J; Nugent DJ; Young G
    Haemophilia; 2004 Jul; 10(4):347-51. PubMed ID: 15230948
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.
    Martinowitz U; Livnat T; Zivelin A; Kenet G
    Haemophilia; 2009 Jul; 15(4):904-10. PubMed ID: 19473416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.